Cargando…
Molecular Biology and Clinical Mitigation of Cancer Treatment-Induced Neuropathy
Disruption of microtubule function is the antitumor mechanism of several classes of drugs used to treat cancer today. However, the significant beneficial effect on tumor outcomes is frequently counterbalanced by neurotoxic complications. Despite an abundance of scientific data, our under-standing of...
Autores principales: | Higa, Gerald M., Sypult, Corbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820064/ https://www.ncbi.nlm.nih.gov/pubmed/27081324 http://dx.doi.org/10.4137/CMO.S32810 |
Ejemplares similares
-
Human amnionic progenitor cell secretome mitigates the consequence of traumatic optic neuropathy in a mouse model
por: McCartan, Robyn, et al.
Publicado: (2023) -
Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development
por: Yang, Yang, et al.
Publicado: (2021) -
Vagus Nerve Stimulation Transiently Mitigates Chemotherapy-Induced Peripheral Neuropathy in Rats
por: Zhang, Ran, et al.
Publicado: (2020) -
Radiation-induced neuropathies in head and neck cancer: prevention and treatment modalities
por: Azzam, Patrick, et al.
Publicado: (2020) -
Drug treatment for chemotherapy-induced peripheral neuropathy in patients with pancreatic cancer
por: Sugimoto, Mitsuru, et al.
Publicado: (2022)